Search

everythinglearnresearchcommunity

for

Search:↓

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

Global oil use will rise, US corn-to-ethanol policy is flawed, and various social and economic issues need attention.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Low-dose oral minoxidil can be effective for hair loss but should be avoided in people with certain heart conditions and severe liver problems.

Finasteride and flutamide can effectively treat hirsutism, with abdominal hairs showing the most sensitivity to the treatment.

Certain groups of medications given when leaving the hospital are linked to a higher risk of negative drug reactions within 30 days, especially in older adults with respiratory issues.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

COVID-19 can cause hair loss starting as early as 18 days after infection.

Certain bacteria from the Citrullus colocynthis plant may be a new source of antibiotics to fight drug-resistant diseases.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Oral retinoic acid effectively treated collodion baby, with hair loss as the main side effect.

Oxygenated micro/nanobubbles speed up burn wound healing in rats.

Chitosan scaffolds with silver nanoparticles effectively treat infected wounds and promote faster healing.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Careful management of chronic hyponatremia is crucial to prevent severe neurological issues.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Nanotechnology shows promise for better chronic wound healing but needs more research.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Testosterone may influence COVID-19 severity and outcomes.

Hair analysis for drugs in psychosis patients is unreliable due to varying hair growth rates.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.